“From 365 to 52 Injections a Year—Is Once-Weekly Insulin the Breakthrough Diabetes Patients Have…

“From 365 to 52 Injections a Year—Is Once-Weekly Insulin the Breakthrough Diabetes Patients Have Been Waiting For?”

🚨 Big Shift in Diabetes Care

What if your patient needed just 1 insulin shot a week instead of daily injections?

The FDA has approved once-weekly basal insulin (icodec-abae) — showing A1C reduction comparable to daily insulin with a familiar safety profile.

💡 Why it matters: • Fewer injections → Better adherence • Less treatment fatigue • Potentially improved long-term outcomes

⚠️ But remember: Careful dose transition, glucose monitoring, and hypoglycemia risk management remain critical.

👨‍⚕️ This isn’t just convenience— It’s a step toward patient-centric, sustainable diabetes care.

👉 Are we ready to rethink how we manage Type 2 Diabetes?

#DiabetesCare #Type2Diabetes #Insulin #Diabetology #HealthcareInnovation #PatientCare #MedEd #ChronicCare #MasterdoctorWellness